Article info
Original article
New tumour antigen PLAC1/CP1, a potentially useful prognostic marker and immunotherapy target for gastric adenocarcinoma
- Correspondence to Professor Fangfang Liu, Department of Pathology, Peking University People's Hospital, Beijing 100044, China; liufangfang{at}pkuph.edu.cn
Citation
New tumour antigen PLAC1/CP1, a potentially useful prognostic marker and immunotherapy target for gastric adenocarcinoma
Publication history
- Received March 1, 2015
- Revised June 17, 2015
- Accepted June 21, 2015
- First published July 8, 2015.
Online issue publication
October 25, 2017
Article Versions
- Previous version (25 October 2017).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions